does tirzepatide help with perimenopause The GLP-1/GIP dual-receptor agonist led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal hormone therapy had the greatest weight What Is GLP-1 Microdosing? How

But if you are already considering a GLP-1 for weight or for type 2 diabetes, new data presented at the American Society of Clinical Oncology Annual Meeting on May 29, 2026 adds something real to that conversation, especially for women in midlife with a family history of breast or other obesity-related cancers

It is how much and how quickly

Symptoms (muscle cramps, arrhythmias, fatigue) and dietary history often provide better clues than blood tests

I know weight loss and maintaining arent easy, because Im living it every single day

If the combination persists beyond 2 to 3 weeks or becomes severe enough to cause dehydration, this warrants a conversation with your healthcare provider